7 unknown. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Unknown 7 |
Follow Hyperuricemia: new trials by email Literature Review of Hyperuricemia trials Research Report on Hyperuricemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Kui-Yuan Chewable Tablets in Patients With Hyperuricemia Kui-Yuan Chewable Tablets, Placedo of Kui-Yuan Chewable Tablets - Hyperuricemia | Phase 4 | Unknown | Quan Jiang | 126 | 2023-07-01 | 2023-06-22 |
| Urate Lowering Therapies and Left Ventricular Diastolic Dysfunction Febuxostat 40 mg, Benzbromarone 50mg, Control - Hyperuricemia, Metabolic Syndrome | Phase 4 | Unknown | National Defense Medical Center, Taiwan | 120 | 2020-02-01 | 2020-04-28 |
| The Impact of Urate-lowering Therapy on Kidney Function (IMPULsKF) Febuxostat 80 MG Oral Tablet or Allopurinol 300 MG Oral Tablet - Gout, CKD Stage 1-4 | Phase 4 | Unknown | Medical Practice Prof D. Ivanov | 2 | 2017-10-30 | 2022-08-24 |
| Lowering-hyperuricemia Treatment on Cardiovascular Outcomes in Peritoneal Dialysis Patients Febuxostat, Placebo - Hyperuricemia | Phase 4 | Unknown | Sun Yat-sen University | 548 | 2017-07-11 | 2020-10-22 |
| The Intervention of Multi-vitamin With Minerals to Hyperuricemia High-dose multi-vitamins with minerals, Low-dose multi-vitamins with minerals, Hypouricemic tablets - Hyperuricemia | Phase 4 | Unknown | Sun Yat-sen University | 200 | 2017-01-01 | 2017-07-14 |
| Effect of Hyperuricaemia on Chronic Renal Disease 20mg Febuxostat, 40mg Febuxostat - Hyperuricemia, Chronic Renal Disease | Phase 4 | Unknown | The Affiliated Hospital of Xuzhou Medical University | 400 | 2017-01-01 | 2018-02-07 |
| Investigation of the Atherogenic Effects of Uric Acid-modified in Endothelial Dysfunction and the the Preventional Mechanism by Anthocyanidines Anthocyanidins capsule, Placebo capsule, Allopurinol - Cardiovascular Disease | Phase 4 | Unknown | Guangzhou General Hospital of Guangzhou Military Command | 320 | 2015-01-01 | 2016-06-13 |
Cardiovascular Diseases (1) · Gout (1) · Metabolic Syndrome (1) · Renal Insufficiency, Chronic (1) · Ventricular Dysfunction, Left (1)
Pathologic Processes (7) · Pathological Conditions, Signs and Symptoms (7) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Arthritis (1) · Cardiovascular Diseases (1) · Chronic Disease (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Crystal Arthropathies (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genetic Diseases, Inborn (1) · Glucose Metabolism Disorders (1) · Heart Diseases (1)
Febuxostat (4) · Allopurinol (2) · Anthocyanins (1) · Benzbromarone (1) · Minerals (1) · Population Groups (1) · Tablets (1)
Sun Yat-sen University (2) · Guangzhou General Hospital of Guangzhou Military Command (1) · Medical Practice Prof D. Ivanov (1) · National Defense Medical Center, Taiwan (1) · Quan Jiang (1) · The Affiliated Hospital of Xuzhou Medical University (1)
China (4) · Taiwan (1) · Ukraine (1)
Cheng-Wei Liu, M.D. (1) · Dong Sun, MD (1) · Min Xia, Ph.D (1) · Xueqing Yu, MD, PhD (1)